Monkeypox to Mpox or the re-emergence of an old zoonosis
Copyright © 2023 Elsevier Masson SAS. All rights reserved..
Monkeypox is a zoonotic disease caused by the Monkeypox virus (MPXV) of the Orthopoxvirus genus. The first human cases occurred in Africa in the 1970s and remained confined to the African continent for a long time until 2003, when several dozen cases occurred in the United States, following contamination by prairie dogs. Unprecedented transmission events have led to more than 80,000 reported cases worldwide between May 2022 and February 2023, primarily affecting men who have sex with men. The changing epidemiology of Mpox has raised concerns about its ability to become endemic beyond its traditional geographic areas. Confirmatory diagnosis is based on direct detection by molecular biology. Pre- or post-exposure smallpox vaccination was widely deployed in early summer 2022 to limit the spread of the disease. In case of severe forms, the use of antivirals can be considered, only tecovirimat being recommended in this indication. The current epidemic has had the merit of showing that a disease that was previously confined to regions of initial virus circulation can spread very rapidly in Western countries and of the need to reinforce the implementation of tools for the surveillance and control of communicable diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2023 |
|---|---|
| Enthalten in: |
Revue francophone des laboratoires : RFL - 2023(2023), 553 vom: 01. Juni, Seite 25-37 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
De la variole du singe à la Mpox ou la réémergence d’une ancienne zoonose |
|---|
| Beteiligte Personen: |
Hantz, Sébastien [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
English Abstract |
|---|
| Anmerkungen: |
Date Revised 20.06.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/S1773-035X(23)00132-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358346134 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358346134 | ||
| 003 | DE-627 | ||
| 005 | 20231226074539.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/S1773-035X(23)00132-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM358346134 | ||
| 035 | |a (NLM)37333061 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Hantz, Sébastien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Monkeypox to Mpox or the re-emergence of an old zoonosis |
| 246 | 3 | 3 | |a De la variole du singe à la Mpox ou la réémergence d’une ancienne zoonose |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Monkeypox is a zoonotic disease caused by the Monkeypox virus (MPXV) of the Orthopoxvirus genus. The first human cases occurred in Africa in the 1970s and remained confined to the African continent for a long time until 2003, when several dozen cases occurred in the United States, following contamination by prairie dogs. Unprecedented transmission events have led to more than 80,000 reported cases worldwide between May 2022 and February 2023, primarily affecting men who have sex with men. The changing epidemiology of Mpox has raised concerns about its ability to become endemic beyond its traditional geographic areas. Confirmatory diagnosis is based on direct detection by molecular biology. Pre- or post-exposure smallpox vaccination was widely deployed in early summer 2022 to limit the spread of the disease. In case of severe forms, the use of antivirals can be considered, only tecovirimat being recommended in this indication. The current epidemic has had the merit of showing that a disease that was previously confined to regions of initial virus circulation can spread very rapidly in Western countries and of the need to reinforce the implementation of tools for the surveillance and control of communicable diseases | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Monkeypoxvirus | |
| 650 | 4 | |a Mpox | |
| 650 | 4 | |a tecovirimat | |
| 650 | 4 | |a vaccination | |
| 650 | 4 | |a variole | |
| 700 | 1 | |a Mafi, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Pinet, Pauline |e verfasserin |4 aut | |
| 700 | 1 | |a Deback, Claire |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue francophone des laboratoires : RFL |d 2006 |g 2023(2023), 553 vom: 01. Juni, Seite 25-37 |w (DE-627)NLM308737768 |x 1773-035X |7 nnns |
| 773 | 1 | 8 | |g volume:2023 |g year:2023 |g number:553 |g day:01 |g month:06 |g pages:25-37 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1773-035X(23)00132-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2023 |j 2023 |e 553 |b 01 |c 06 |h 25-37 | ||